These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 17419056)

  • 21. The influence of modifications in imide fragment structure on 5-HT(1A) and 5-HT(7) receptor affinity and in vivo pharmacological properties of some new 1-(m-trifluoromethylphenyl)piperazines.
    Paluchowska MH; Bugno R; Duszyńska B; Tatarczyńska E; Nikiforuk A; Lenda T; Chojnacka-Wójcik E
    Bioorg Med Chem; 2007 Nov; 15(22):7116-25. PubMed ID: 17825569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural modifications of N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinehexanamides: influence on lipophilicity and 5-HT7 receptor activity. Part III.
    Leopoldo M; Lacivita E; De Giorgio P; Fracasso C; Guzzetti S; Caccia S; Contino M; Colabufo NA; Berardi F; Perrone R
    J Med Chem; 2008 Sep; 51(18):5813-22. PubMed ID: 18800769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation of piperazine derivatives as 5-HT7 receptor antagonists.
    Yoon J; Yoo EA; Kim JY; Pae AN; Rhim H; Park WK; Kong JY; Park Choo HY
    Bioorg Med Chem; 2008 May; 16(10):5405-12. PubMed ID: 18456500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parallel solid-phase synthesis and characterization of new sulfonamide and carboxamide proline derivatives as potential CNS agents.
    Zajdel P; Subra G; Bojarski AJ; Duszyńska B; Pawłowski M; Martinez J
    Bioorg Med Chem; 2005 Apr; 13(8):3029-35. PubMed ID: 15781412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Affinity of cyamemazine metabolites for serotonin, histamine and dopamine receptor subtypes.
    Benyamina A; Arbus C; Nuss P; Garay RP; Neliat G; Hameg A
    Eur J Pharmacol; 2008 Jan; 578(2-3):142-7. PubMed ID: 17936750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on a series of potent, orally bioavailable, 5-HT(1) receptor ligands--part II.
    Ward SE; Eddershaw P; Flynn ST; Gordon L; Lovell PJ; Moore SH; Scott CM; Smith PW; Thewlis KM; Wyman PA
    Bioorg Med Chem Lett; 2009 Jan; 19(2):428-32. PubMed ID: 19071020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel 1-(azacyclyl)-3-arylsulfonyl-1H-pyrrolo[2,3-b]pyridines as 5-HT6 agonists and antagonists.
    Elokdah H; Li D; McFarlane G; Bernotas RC; Robichaud AJ; Magolda RL; Zhang GM; Smith D; Schechter LE
    Bioorg Med Chem; 2007 Sep; 15(18):6208-26. PubMed ID: 17624788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Receptor-based pharmacophores for serotonin 5-HT7R antagonists-implications to selectivity.
    Kołaczkowski M; Nowak M; Pawłowski M; Bojarski AJ
    J Med Chem; 2006 Nov; 49(23):6732-41. PubMed ID: 17154504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclic guanidines as dual 5-HT5A/5-HT7 receptor ligands: optimising brain penetration.
    Peters JU; Lübbers T; Alanine A; Kolczewski S; Blasco F; Steward L
    Bioorg Med Chem Lett; 2008 Jan; 18(1):262-6. PubMed ID: 18023344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-activity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinehexanamides, a class of 5-HT7 receptor agents. 2.
    Leopoldo M; Lacivita E; Contino M; Colabufo NA; Berardi F; Perrone R
    J Med Chem; 2007 Aug; 50(17):4214-21. PubMed ID: 17649988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a novel series of 3-piperidinyl-5-sulfonylindazoles as potent 5-HT6 ligands.
    Liu KG; Lo JR; Comery TA; Zhang GM; Zhang JY; Kowal DM; Smith DL; Di L; Kerns EH; Schechter LE; Robichaud AJ
    Bioorg Med Chem Lett; 2009 Jun; 19(12):3214-6. PubMed ID: 19433358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Designing selective, high affinity ligands of 5-HT1D receptor by covalent dimerization of 5-HT1F ligands derived from 4-fluoro-N-[3-(1-methyl-4-piperidinyl)-1H-indol-5-yl]benzamide.
    Choi SK; Green D; Ho A; Klein U; Marquess D; Taylor R; Turner SD
    J Med Chem; 2008 Jun; 51(12):3609-16. PubMed ID: 18507369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diaminopyrimidine and diaminopyridine 5-HT7 ligands.
    Denhart DJ; Purandare AV; Catt JD; King HD; Gao A; Deskus JA; Poss MA; Stark AD; Torrente JR; Johnson G; Mattson RJ
    Bioorg Med Chem Lett; 2004 Aug; 14(16):4249-52. PubMed ID: 15261280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a series of benzoxazoles as potent 5-HT6 ligands.
    Liu KG; Lo JR; Comery TA; Zhang GM; Zhang JY; Kowal DM; Smith DL; Di L; Kerns EH; Schechter LE; Robichaud AJ
    Bioorg Med Chem Lett; 2009 Feb; 19(4):1115-7. PubMed ID: 19152787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. R-(-)-N-alkyl-11-hydroxy-10-hydroxymethyl- and 10-methyl-aporphines as 5-HT1A receptor ligands.
    Si YG; Gardner MP; Tarazi FI; Baldessarini RJ; Neumeyer JL
    Bioorg Med Chem Lett; 2007 Aug; 17(15):4128-30. PubMed ID: 17543523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and receptor binding of new thieno[2,3-d]-pyrimidines as selective ligands of 5-HT(3) receptors.
    Modica MN; Romeo G; Salerno L; Pittalà V; Siracusa MA; Mereghetti I; Cagnotto A; Mennini T; Gáspár R; Gál A; Falkay G; Palkó M; Maksay G; Fülöp F
    Arch Pharm (Weinheim); 2008 Jun; 341(6):333-43. PubMed ID: 18535994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of 5-HT6 receptor ligands based on virtual HTS.
    Tasler S; Kraus J; Wuzik A; Müller O; Aschenbrenner A; Cubero E; Pascual R; Quintana-Ruiz JR; Dordal A; Mercè R; Codony X
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6224-9. PubMed ID: 17892934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 3,4-Dihydro-2H-benzo[1,4]oxazine derivatives as 5-HT6 receptor antagonists.
    Zhao SH; Berger J; Clark RD; Sethofer SG; Krauss NE; Brothers JM; Martin RS; Misner DL; Schwab D; Alexandrova L
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3504-7. PubMed ID: 17485206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indene-based scaffolds. Design and synthesis of novel serotonin 5-HT6 receptor ligands.
    Alcalde E; Mesquida N; Frigola J; López-Pérez S; Mercè R
    Org Biomol Chem; 2008 Oct; 6(20):3795-810. PubMed ID: 18843410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Memory time-course: mRNA 5-HT1A and 5-HT7 receptors.
    Perez-Garcia G; Meneses A
    Behav Brain Res; 2009 Aug; 202(1):102-13. PubMed ID: 19447286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.